We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01453088
Recruitment Status : Recruiting
First Posted : October 17, 2011
Last Update Posted : August 9, 2017
Information provided by (Responsible Party):
Hackensack University Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : March 2018
  Estimated Study Completion Date : March 2018